Scriptaid
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Scriptaid
Description:
Scriptaid is a potent histone deacetylase (HDAC) inhibitor, used in cancer research. Scriptaid is also a sensitizer to antivirals and has potential for epstein-barr virus (EBV) -associated lymphomas treatment.Product Name Alternative:
Scriptide; GCK1026UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Apoptosis; Autophagy; HDAC; Influenza VirusType:
Reference compoundRelated Pathways:
Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; EpigeneticsApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/Scriptaid.htmlPurity:
98.59Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
O=C(NO)CCCCCN(C(C1=CC=CC2=CC=CC3=C12)=O)C3=OMolecular Formula:
C18H18N2O4Molecular Weight:
326.35Precautions:
H302, H315, H319, H335References & Citations:
[1]Keen JC, et al. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Breast Cancer Res Treat. 2003 Oct;81 (3) :177-86.|[2]Strobl JS, et al. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. J Parasitol. 2007 Jun;93 (3) :694-700.|[3]Janaki Ramaiah M, et al. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects. Gene. 2017 Sep 5;627:379-386.|[4]Ghosh SK, et al. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 2012 Jan 26;119 (4) :1008-17.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
HDACCAS Number:
[287383-59-9]
